chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Injection site erythema, Injection site pain, Injection site rash, Injection site swelling
Clinical narrative: Swelling, pain and red rash around injection site, about size of baseball; Swelling, pain and red rash around injection site, about size of baseball; Swelling, pain and red rash around injection site, about size of baseball; Swelling, pain and red rash around injection site, about size of baseball; dose 2 administration date=07Jan2021/ dose 1administration date=18Dec2020; This is a spontaneous report from a contactable healthcare professional (patient) reported for herself that a 30-year-old female patient (non-pregnant) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EK9231) via an unspecified route of administration at right arm, on 07Jan2021 14:30 at single dose for COVID-19 immunisation. Medical history was none. Patient did not have COVID prior vaccination. Patient has no known allergies. Concomitant medications were not reported. Patient previously received first dose of BNT162B2 (Lot number: EH9899) on 18Dec2020 15:00 at left arm for COVID-19 immunisation at the age of 30 years old. The patient experienced swelling, pain and red rash around injection site, about size of baseball on 07Jan2021 16:00. No treatment received for events. Patient did not test COVID post vaccination. Patient did not receive other vaccine in four weeks. Outcome of swelling, pain and red rash around injection site, about size of baseball was recovering, outcome of other event was unknown.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Inappropriate schedule of product administration, Myalgia
Clinical narrative: Fever; muscle aches; joint pain; tiredness; headache; BNT162B2 first dose on 21Dec2020 and second dose on 09Jan2021, spaced less than 3 weeks; This is a spontaneous report from a contactable nurse (patient self). A 34-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL3246), via an unspecified route of administration on 09Jan2021 at single dose on left arm for COVID-19 immunisation. Medical history included gastrooesophageal reflux disease (GERD).  Patient had no known allergies. The patient's concomitant medications were not reported. Historical vaccine included first dose of bnt162b2 (lot: EL0140) on 21Dec2020 12:00 pm left arm for COVID-19 immunisation. Patient experienced fever, muscle aches, joint pain, tiredness, headache on 10Jan2021 02:00 am with outcome recovering. No treatment was received for the events.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; muscle aches; joint pain; tiredness; headache; BNT162B2 first dose on 21Dec2020 and second dose on 09Jan2021, spaced less than 3 weeks; This is a spontaneous report from a contactable nurse (patient self). A 34-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL3246), via an unspecified route of administration on 09Jan2021 at single dose on left arm for COVID-19 immunisation. Medical history included gastrooesophageal reflux disease (GERD).  Patient had no known allergies. The patient's concomitant medications were not reported. Historical vaccine included first dose of bnt162b2 (lot: EL0140) on 21Dec2020 12:00 pm left arm for COVID-19 immunisation. Patient experienced fever, muscle aches, joint pain, tiredness, headache on 10Jan2021 02:00 am with outcome recovering. No treatment was received for the events.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Dyspnoea, Fatigue, Headache, Oropharyngeal pain
Clinical narrative: sore throat; mild difficulty breathing; mild fever (99.1); fatigue; throbbing headache(6/10 pain); This is a spontaneous report from a contactable healthcare professional.  A non-pregnant 26-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EH 9899), via an unspecified route of administration in the left arm on 18Dec2020 16:00 at a single dose for COVID-19 immunization.  Medical history included gastrooesophageal reflux disease (GERD), irritable bowel syndrome (IBS), gastritis, asthma, anxiety/depression, allergies: penicillin.  Concomitant medication included salbutamol (ALBUTEROL HFA), pantoprazole (MANUFACTURER UNKNOWN), fluoxetine (MANUFACTURER UNKNOWN), cholestyramine (MANUFACTURER UNKNOWN).  The patient previously took cefalexin monohydrate (KEFLEX) and lactose (MANUFACTURER UNKNOWN) and experienced allergies.  On 18Dec2020, the patient experienced a sore throat, mild difficulty breathing, mild fever (99.1), fatigue and throbbing headache (6/10 pain).  Clinical details were reported as follows: On 18Dec2020, the patient had a sore throat and mild difficulty breathing. The patient took albuterol, which helped a little. The patient had a mild fever (99.1) for two days after the shot, as well as fatigue, and a throbbing headache (6/10 pain) for a week and a half. Acetaminophen (TYLENOL) helped manage the pain, and sleep helped the pain get better. The patient underwent lab tests and procedures on 18Dec2020 which included pain: 6/10 and body temperature: 99.1.  The clinical outcome of the events was recovering.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Pain assessment, Pyrexia
Clinical narrative: sore throat; mild difficulty breathing; mild fever (99.1); fatigue; throbbing headache(6/10 pain); This is a spontaneous report from a contactable healthcare professional.  A non-pregnant 26-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EH 9899), via an unspecified route of administration in the left arm on 18Dec2020 16:00 at a single dose for COVID-19 immunization.  Medical history included gastrooesophageal reflux disease (GERD), irritable bowel syndrome (IBS), gastritis, asthma, anxiety/depression, allergies: penicillin.  Concomitant medication included salbutamol (ALBUTEROL HFA), pantoprazole (MANUFACTURER UNKNOWN), fluoxetine (MANUFACTURER UNKNOWN), cholestyramine (MANUFACTURER UNKNOWN).  The patient previously took cefalexin monohydrate (KEFLEX) and lactose (MANUFACTURER UNKNOWN) and experienced allergies.  On 18Dec2020, the patient experienced a sore throat, mild difficulty breathing, mild fever (99.1), fatigue and throbbing headache (6/10 pain).  Clinical details were reported as follows: On 18Dec2020, the patient had a sore throat and mild difficulty breathing. The patient took albuterol, which helped a little. The patient had a mild fever (99.1) for two days after the shot, as well as fatigue, and a throbbing headache (6/10 pain) for a week and a half. Acetaminophen (TYLENOL) helped manage the pain, and sleep helped the pain get better. The patient underwent lab tests and procedures on 18Dec2020 which included pain: 6/10 and body temperature: 99.1.  The clinical outcome of the events was recovering.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Myalgia, Vaccination site pain
Clinical narrative: Sore muscle at injection site, fatigue, joint pain; Sore muscle at injection site, fatigue, joint pain; Sore muscle at injection site, fatigue, joint pain; Sore muscle at injection site, fatigue, joint pain; This is a spontaneous report from a contactable nurse (patient). A 67-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EK9231), via an unspecified route of administration on 07Jan2021 09:45 at single dose for covid-19 immunization. Vaccine location was left arm. Patient received the first dose on 17Dec2020 08:45 AM (lot number EK5730) at right arm for covid-19 immunization. Patient is not pregnant. The facility type vaccine was hospital. Medical history included hypertension, elevated cholesterol. Known allergies included Sulfa. Concomitant medication included losartan, hctz, atorvastatin, zinc, ergocalciferol (VIT D). Patient was not diagnosed with COVID-19 prior to vaccination nor tested for COVID-19 since the vaccination. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced sore muscle at injection site, fatigue, joint pain on 07Jan2021 10:00 AM. Patient didn't receive treatment for the adverse events. The outcome of events was recovered in Jan2021.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Flushing, Rosacea
Clinical narrative: rosacea flare up; facial flushing; This is a spontaneous report from a contactable consumer (reported for himself). A 62-year-old female patient (not pregnant) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1658), via an unspecified route of administration on 06Jan2021 12:15 at single dose at left arm for COVID-19 immunization. Medical history included asthma; osteoporosis; dry eye; Known allergies: Omnipaque CT injection fluid; environmental allergies including pollen and dust mites; rosacea he had many years ago including facial redness and burning. Concomitant medication included fluticasone propionate (FLOVENT). The patient previously took denosumab (PROLIA) injection last taken on 06Aug2020. Facility type vaccine was Hospital. No other vaccine in four weeks. About eight hours after the injection the patient started having facial flushing and was advised to go to an emergency room. Patient saw Dr. (Name) at (Institution name) who prescribed Benadryl, Prednisone and Pepcid and the facial flushing subsided but came back the next day. The patient had been experiencing a recurrence of symptoms due to a rosacea flare up that he had many years ago including facial redness and burning. Adverse events start date on 06Jan2021 20:00 and resulted in Emergency room/department or urgent care. The patient didn't have COVID prior vaccination and didn't have COVID tested post vaccination. The outcome of the events was recovered with lasting effects.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia, Pyrexia
Clinical narrative: Chills; Headache; Muscle Aches; Fatigue; Fever; This is a spontaneous report from a contactable physician reported for himself.   This 65-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot # EL0142), via an unspecified route of administration at single dose in the right arm on 08Jan2021 10:00 for covid-19 immunisation. Medical history included hypertension. Concomitant medication included lisinopril, chlorthalidone, ascorbic acid;vitamin d nos;zinc. Previously the patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot # EK5730), in the left arm on 19Dec2020 for covid-19 immunisation. On 09Jan2021 02:30, the patient experienced fatigue, fever, chills, headache, muscle aches, all with outcome of recovering. No treatment required. The vaccine was administered at Hospital Facility. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Headache, Myalgia, Pyrexia
Clinical narrative: Fever of 101.1; headache; extreme fatigue; muscle pain; This is a spontaneous report from a contactable nurse (patient). A 55-year-old female patient (non-pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EJ1685), intramuscular on 07Jan2021 14:00 at single dose at left arm for covid-19 immunization. Medical history was none, no known allergies. Concomitant medications in two weeks included venlafaxine, levothyroxine sodium (SYNTHROID). Patient didn't receive any other vaccines in 4 weeks. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient had not been tested for COVID-19. The patient experienced fever of 101.1, headache, extreme fatigue, muscle pain on 08Jan2021 with outcome of recovered on 10Jan2021. These symptoms subsided after 2 days. Patient didn't receive treatment for events. The adverse events resulted in neither doctor or other healthcare professional office/clinic visit, nor emergency room/department or urgent care.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Cold sweat, Fatigue, Myalgia
Clinical narrative: Severe muscle ache, joint pain, fatigue, cold sweats, chills, injection site swelling; Severe muscle ache, joint pain, fatigue, cold sweats, chills, injection site swelling; Severe muscle ache, joint pain, fatigue, cold sweats, chills, injection site swelling; Severe muscle ache, joint pain, fatigue, cold sweats, chills, injection site swelling; Severe muscle ache, joint pain, fatigue, cold sweats, chills, injection site swelling; Severe muscle ache, joint pain, fatigue, cold sweats, chills, injection site swelling; This is a spontaneous report from a contactable Nurse (patient). A 34-years-old female patient received second dose of bnt162b2 (BNT162B2 lot number=EK9231), via an unspecified route of administration on 08Jan2021 08:00 at SINGLE DOSE on arm left for covid-19 immunisation. The patient medical history was none. Known allergies: None. Concomitant medication included vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]), vitamin d3 (VITAMIN D3), zinc (ZINC), fluticasone propionate (FLONASE [FLUTICASONE PROPIONATE]) and Multivitamins. The patient previous received product=COVID 19, brand=Pfizer, Lot number=EL0140, Administration date=18Dec2020, Administration time=08:15 AM, Vaccine location=Left arm, Dose number=1. On 18Dec2020 04:00 PM patient experienced sudden onset severe muscle aches, joint pain, nausea, lightheaded, fever, cold sweats and fatigue. After the second dose, the patient experienced severe muscle ache, joint pain, fatigue, cold sweats, chills, injection site swelling on 08Jan2021 19:00 with outcome of recovering. No treatment was received. The patient had no covid prior vaccination; no covid tested post vaccination.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Severe muscle ache, joint pain, fatigue, cold sweats, chills, injection site swelling; Severe muscle ache, joint pain, fatigue, cold sweats, chills, injection site swelling; Severe muscle ache, joint pain, fatigue, cold sweats, chills, injection site swelling; Severe muscle ache, joint pain, fatigue, cold sweats, chills, injection site swelling; Severe muscle ache, joint pain, fatigue, cold sweats, chills, injection site swelling; Severe muscle ache, joint pain, fatigue, cold sweats, chills, injection site swelling; This is a spontaneous report from a contactable Nurse (patient). A 34-years-old female patient received second dose of bnt162b2 (BNT162B2 lot number=EK9231), via an unspecified route of administration on 08Jan2021 08:00 at SINGLE DOSE on arm left for covid-19 immunisation. The patient medical history was none. Known allergies: None. Concomitant medication included vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]), vitamin d3 (VITAMIN D3), zinc (ZINC), fluticasone propionate (FLONASE [FLUTICASONE PROPIONATE]) and Multivitamins. The patient previous received product=COVID 19, brand=Pfizer, Lot number=EL0140, Administration date=18Dec2020, Administration time=08:15 AM, Vaccine location=Left arm, Dose number=1. On 18Dec2020 04:00 PM patient experienced sudden onset severe muscle aches, joint pain, nausea, lightheaded, fever, cold sweats and fatigue. After the second dose, the patient experienced severe muscle ache, joint pain, fatigue, cold sweats, chills, injection site swelling on 08Jan2021 19:00 with outcome of recovering. No treatment was received. The patient had no covid prior vaccination; no covid tested post vaccination.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore injection site; This is a spontaneous report from a contactable pharmacist (patient). A 26-years-old female patient (not pregnant) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 23Dec2020 08:45 at single dose on right arm for covid-19 immunisation. Medical history included asthma. Concomitant medication included cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]). No Covid prior vaccination. The patient previously took bactrim and experienced drug hypersensitivity. The patient experienced sore injection site on 24Dec2020 12:00. Outcome of event was recovered. No treatment received. No covid tested post vaccination.  Information about Lot/batch number has been requested.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, SARS-CoV-2 test, Vaccination site pain
Clinical narrative: Chills; Headache; Site pain; Body ache; This is a Spontaneous report from a contactable Nurse (patient). A 41-years-old female patient (no pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) , intramuscular on 09Jan2021 08:45 (lot number EL0142) at the second single dose, intramuscular on 21Dec2020 11:15 (lot number EH9899) at the first single dose for covid-19 immunisation. Anatomical location was left arm.  Medical history reported as none.  The patient's concomitant medications were not reported.  The patient experienced chills, headache, site pain, body ache on 09Jan2021 21:00.  The patient underwent lab tests and procedures which included Covid testing viral RNA: negative on 04Jun2020 via Nasal Swab. The outcome of events was unknown.No other vaccine in four weeks; No covid prior vaccination; No covid tested post vaccination
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Drug hypersensitivity, Headache, Nausea, Oral disorder, Oral mucosal eruption
Clinical narrative: taking new meds for allergic; red spots on roof of mouth; bumps on roof of mouth; rash around the corners of my mouth; sore arm; nausea; headache; This is a spontaneous report from a contactable consumer. This consumer reported for that the 60-year-old female patient who received first dose of bnt162b2 (Pfizer Pfizerbiontech covide-19 Vaccine EUA), via an unspecified route of administration on 03Jan2021 10:00 AM on Left arm at single dose for covid-19 immunisation. She is not pregnant. Medical history included Known allergies: Penicillin sulfa. No other vaccine in four weeks. Concomitant medications included in two weeks: escitalopram oxalate (LEXAPRO), valaciclovir hydrochloride (VALTREX). The patient experienced Day 1 sore arm, nausea, headache from 05Jan2021 12:00AM, Day 2 nausea from 06Jan2021, Day 3 rash around the corners of my mouth from 07Jan2021, Day 4 bumps on roof of mouth from 08Jan2021, Day 5 red spots on roof of mouth from 09Jan2021, Day 6 Continued red spots went to Doctor, Day 7 taking new meds for allergic reaction from 11Jan2021, Day 8 headache mouth improving. AE resulted in Doctor or other healthcare professional office/clinic visit. The outcome of the events was recovering. Treatment was received included Doxycycline. No covid prior vaccination. No covid tested post vaccination.  No follow-up attempts are possible; information about batch/lot number cannot be obtained.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Rash macular
Clinical narrative: taking new meds for allergic; red spots on roof of mouth; bumps on roof of mouth; rash around the corners of my mouth; sore arm; nausea; headache; This is a spontaneous report from a contactable consumer. This consumer reported for that the 60-year-old female patient who received first dose of bnt162b2 (Pfizer Pfizerbiontech covide-19 Vaccine EUA), via an unspecified route of administration on 03Jan2021 10:00 AM on Left arm at single dose for covid-19 immunisation. She is not pregnant. Medical history included Known allergies: Penicillin sulfa. No other vaccine in four weeks. Concomitant medications included in two weeks: escitalopram oxalate (LEXAPRO), valaciclovir hydrochloride (VALTREX). The patient experienced Day 1 sore arm, nausea, headache from 05Jan2021 12:00AM, Day 2 nausea from 06Jan2021, Day 3 rash around the corners of my mouth from 07Jan2021, Day 4 bumps on roof of mouth from 08Jan2021, Day 5 red spots on roof of mouth from 09Jan2021, Day 6 Continued red spots went to Doctor, Day 7 taking new meds for allergic reaction from 11Jan2021, Day 8 headache mouth improving. AE resulted in Doctor or other healthcare professional office/clinic visit. The outcome of the events was recovering. Treatment was received included Doxycycline. No covid prior vaccination. No covid tested post vaccination.  No follow-up attempts are possible; information about batch/lot number cannot be obtained.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Chills, Fatigue, Headache, Influenza like illness
Clinical narrative: flu-like symptoms; Mainly flu-like symptoms such as chills, body aches, fatigue, headache; Mainly flu-like symptoms such as chills, body aches, fatigue, headache; Mainly flu-like symptoms such as chills, body aches, fatigue, headache; Mainly flu-like symptoms such as chills, body aches, fatigue, headache; Feeling exhausted; Very swollen at injection site with redness; Very swollen at injection site with redness; Enlarged lymph nodes on right axilla with pain in left axilla; Enlarged lymph nodes on right axilla with pain in left axilla; This is a spontaneous report from a contactable Nurse (patient). This 39-year-old female Nurse (no pregnant) received the second dose of BNT162B2 (lot number=EL 1284) Intramuscular on 08Jan2021 05:45 PM on Left arm for covid-19 immunization. Medical history was High Blood Pressure, Depression. Concomitant drug included Labetalol, Lisinopril, bupropion hydrochloride (WELLBUTRIN). Past drug was the first dose of BNT162B2 (lot number=EH9899, vaccine location=Left arm) Intramuscular on 18Dec2020 01:30 PM. Patient experienced Mainly flu-like symptoms such as chills, body aches, fatigue, headache. Feeling exhausted. Very swollen at injection site with redness. Enlarged lymph nodes on right axilla with pain in left axilla on 09Jan2021 01:30 PM. Outcome of the event was recovering. No other vaccine in four weeks. No treatment. No covid prior vaccination. No covid tested post vaccination.  Follow-up attempts are completed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pain, Vaccination site erythema, Vaccination site swelling
Clinical narrative: flu-like symptoms; Mainly flu-like symptoms such as chills, body aches, fatigue, headache; Mainly flu-like symptoms such as chills, body aches, fatigue, headache; Mainly flu-like symptoms such as chills, body aches, fatigue, headache; Mainly flu-like symptoms such as chills, body aches, fatigue, headache; Feeling exhausted; Very swollen at injection site with redness; Very swollen at injection site with redness; Enlarged lymph nodes on right axilla with pain in left axilla; Enlarged lymph nodes on right axilla with pain in left axilla; This is a spontaneous report from a contactable Nurse (patient). This 39-year-old female Nurse (no pregnant) received the second dose of BNT162B2 (lot number=EL 1284) Intramuscular on 08Jan2021 05:45 PM on Left arm for covid-19 immunization. Medical history was High Blood Pressure, Depression. Concomitant drug included Labetalol, Lisinopril, bupropion hydrochloride (WELLBUTRIN). Past drug was the first dose of BNT162B2 (lot number=EH9899, vaccine location=Left arm) Intramuscular on 18Dec2020 01:30 PM. Patient experienced Mainly flu-like symptoms such as chills, body aches, fatigue, headache. Feeling exhausted. Very swollen at injection site with redness. Enlarged lymph nodes on right axilla with pain in left axilla on 09Jan2021 01:30 PM. Outcome of the event was recovering. No other vaccine in four weeks. No treatment. No covid prior vaccination. No covid tested post vaccination.  Follow-up attempts are completed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Influenza like illness, Lymph node pain, Lymphadenopathy
Clinical narrative: Tiredness; muscle and joint pain; muscle and joint pain; injection site pain; nausea; multiple swollen lymph nodes in the side of neck that are painful and the size of llama beans, nickels and dimes; multiple swollen lymph nodes in the side of neck that are painful and the size of llama beans, nickels and dimes; I fell like I have a bad flu; This is a spontaneous report from a contactable Nurse (patient). A 42-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number: Ek5730, intramuscularly in left arm on 18Dec2020 10:30 AM at single dose for COVID-19 immunisation. Facility type vaccine was hospital. Medical history was none, no known allergies. The patient didn't have COVID prior vaccination. Concomitant medication in 2 weeks included ibuprofen, phentermine, paracetamol (TYLENOL), valacyclovir. The patient didn't have other vaccine in four weeks. The patient experienced tiredness, muscle and joint pain, injection site pain, nausea, multiple swollen lymph nodes in the side of neck that were painful and the size of llama beans, nickels and dimes. She felt like she had a bad flu. Adverse events start date was 02Jan2021 08:30 AM. It was unknown if treatment was received for the events. COVID was not tested post vaccination. Outcome of the events was recovering. The patient received the second dose of BNT162B2, lot number: Ek9231, intramuscularly in left arm on 08Jan2021, 06:15 PM.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Vaccination site pain
Clinical narrative: Tiredness; muscle and joint pain; muscle and joint pain; injection site pain; nausea; multiple swollen lymph nodes in the side of neck that are painful and the size of llama beans, nickels and dimes; multiple swollen lymph nodes in the side of neck that are painful and the size of llama beans, nickels and dimes; I fell like I have a bad flu; This is a spontaneous report from a contactable Nurse (patient). A 42-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number: Ek5730, intramuscularly in left arm on 18Dec2020 10:30 AM at single dose for COVID-19 immunisation. Facility type vaccine was hospital. Medical history was none, no known allergies. The patient didn't have COVID prior vaccination. Concomitant medication in 2 weeks included ibuprofen, phentermine, paracetamol (TYLENOL), valacyclovir. The patient didn't have other vaccine in four weeks. The patient experienced tiredness, muscle and joint pain, injection site pain, nausea, multiple swollen lymph nodes in the side of neck that were painful and the size of llama beans, nickels and dimes. She felt like she had a bad flu. Adverse events start date was 02Jan2021 08:30 AM. It was unknown if treatment was received for the events. COVID was not tested post vaccination. Outcome of the events was recovering. The patient received the second dose of BNT162B2, lot number: Ek9231, intramuscularly in left arm on 08Jan2021, 06:15 PM.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Investigation, Pain
Clinical narrative: Stabbing head ache, chills, and body aches; Stabbing head ache, chills, and body aches; Stabbing head ache, chills, and body aches; This is a spontaneous report from a contactable other healthcare professional (patient). A 22-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on arm left on 09Jan2021 16:45 at single dose for COVID-19 immunization. The patient was diagnosed as COVID prior vaccination. The patient's concomitant medications were not reported. The patient did not receive other vaccine in four weeks. The patient did not have COVID tested post vaccination. The patient experienced stabbing head ache, chills, and body aches on 10Jan2021 with outcome of not recovered. No treatment was received for the events.  Information on Lot/ Batch number has been requested.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Hyperhidrosis
Clinical narrative: headache; sweating; severe chills; fatigue/more fatigue; fever 100.6 F/fever peaked at 102 F/fever down to 100.4; felt like had the flu.; This is a spontaneous report from a contactable pharmacist (patient). A 26-year-old female patient (not pregnant) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number= EK4176), via an unspecified route of administration at left arm on 08Jan2021 07:45 AM at single dose for covid-19 immunization. The COVID-19 vaccine was administered at Hospital. The patient's medical history included Deep vein thrombosis (DVT) from 2017. Concomitant medication included naproxen, doxycycline and women's multivitamin.  The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number= EK5730) via an unspecified route of administration at left arm on 18Dec2020 09:15 PM at single dose for covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. 14 hours after second dose, the patient experienced severe chills and fatigue, fever 100.6 F, felt like had the flu. 16 hours fever peaked at 102 F, 26 hours, chills gone, fever down to 100.4, new onset headache and sweating, more fatigue. Onset date of events chills, fatigue, fever and felt like flu was provided on 08Jan2021 at time of 08:00 PM. Onset date of events headache and sweating was provided 09Jan2021 09:45 AM. No treatment received for the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the events was recovered in Jan2021.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Pyrexia
Clinical narrative: headache; sweating; severe chills; fatigue/more fatigue; fever 100.6 F/fever peaked at 102 F/fever down to 100.4; felt like had the flu.; This is a spontaneous report from a contactable pharmacist (patient). A 26-year-old female patient (not pregnant) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number= EK4176), via an unspecified route of administration at left arm on 08Jan2021 07:45 AM at single dose for covid-19 immunization. The COVID-19 vaccine was administered at Hospital. The patient's medical history included Deep vein thrombosis (DVT) from 2017. Concomitant medication included naproxen, doxycycline and women's multivitamin.  The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number= EK5730) via an unspecified route of administration at left arm on 18Dec2020 09:15 PM at single dose for covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. 14 hours after second dose, the patient experienced severe chills and fatigue, fever 100.6 F, felt like had the flu. 16 hours fever peaked at 102 F, 26 hours, chills gone, fever down to 100.4, new onset headache and sweating, more fatigue. Onset date of events chills, fatigue, fever and felt like flu was provided on 08Jan2021 at time of 08:00 PM. Onset date of events headache and sweating was provided 09Jan2021 09:45 AM. No treatment received for the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the events was recovered in Jan2021.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Flushing, Hypoaesthesia, Lip pruritus, Nasal oedema, Paraesthesia
Clinical narrative: tongue itching; lips itching; face feels flushed; left hand is tingling or numb (the palm)/left hand that's puffy and tingling; left hand is tingling or numb (the palm)/left hand that's puffy and tingling; left hand is tingling or numb (the palm)/left hand that's puffy and tingling; palm of left hand was itchy; inside of nose; it feels like someone is pinching nose/It's swelling; inside of nose; it feels like someone is pinching nose/It's swelling; face has a rashly feeling; This is a spontaneous report from a contactable consumer reported for self. This 62-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number unknown) via unspecified route of administration on an unspecified date at single dose in left arm for COVID-19 immunisation. The patient medical history and concomitant mediations not provided. The patient reported that she had the vaccine at her work, waited 15 minutes and left the clinic. About 20 minutes then, her tongue was itching, lips were itching; face felt flushed. Face had a rashly feeling. Her left hand was tingling or numb (the palm). Her palm of left hand was tingling and itchy. The inside of nose; it feels like someone is pinching nose. It was swelling. The patient stated "Whenever I get stung by bees, this is how I feel". The patient stated that it was mild. She stated she was having a reaction, but not severe enough maybe it will subside. Her left arm is where she got the injection and it was left hand that was puffy and tingling. The patient stated that she also had N95 mask on and she guess she get that reaction from it. The patient stated that she was just wondering what she should do, if she should just go by some diphenhydramine hydrochloride (BENADRYL). The outcome of events was not reported.   Information about lot/batch number has been requested.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pruritus, Rash, Rhinalgia, Tongue pruritus
Clinical narrative: tongue itching; lips itching; face feels flushed; left hand is tingling or numb (the palm)/left hand that's puffy and tingling; left hand is tingling or numb (the palm)/left hand that's puffy and tingling; left hand is tingling or numb (the palm)/left hand that's puffy and tingling; palm of left hand was itchy; inside of nose; it feels like someone is pinching nose/It's swelling; inside of nose; it feels like someone is pinching nose/It's swelling; face has a rashly feeling; This is a spontaneous report from a contactable consumer reported for self. This 62-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number unknown) via unspecified route of administration on an unspecified date at single dose in left arm for COVID-19 immunisation. The patient medical history and concomitant mediations not provided. The patient reported that she had the vaccine at her work, waited 15 minutes and left the clinic. About 20 minutes then, her tongue was itching, lips were itching; face felt flushed. Face had a rashly feeling. Her left hand was tingling or numb (the palm). Her palm of left hand was tingling and itchy. The inside of nose; it feels like someone is pinching nose. It was swelling. The patient stated "Whenever I get stung by bees, this is how I feel". The patient stated that it was mild. She stated she was having a reaction, but not severe enough maybe it will subside. Her left arm is where she got the injection and it was left hand that was puffy and tingling. The patient stated that she also had N95 mask on and she guess she get that reaction from it. The patient stated that she was just wondering what she should do, if she should just go by some diphenhydramine hydrochloride (BENADRYL). The outcome of events was not reported.   Information about lot/batch number has been requested.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Myalgia, Nausea, Vaccination site joint movement impairment, Vaccination site pain
Clinical narrative: Mild myalgias 36h after on 19Dec2020 02:30; Intermittent mild Dizziness and nausea 24h after vaccine; Intermittent mild Dizziness and nausea 24h after vaccine; Pain at side of puncture, unable to lift arm from 12h to 40 hours after; unable to lift arm from 12h to 40 hours after; This is a spontaneous report from a contactable Physician(patient). A 32-year-old female patient received first dose BNT162B2 (lot number EH9899) , via an unspecified route of administration at Arm Right on 17Dec2020 14:30 at the 32 years old at single dose for COVID-19 immunization.  The medical history was not reported. The concomitant medication was levothyroxine. The patient experienced Pain at side of puncture on 18Dec2020 12:00, unable to lift arm from 12h on 18Dec2020 02:30 to 40 hours after on 20Dec2020 06:30, Intermittent mild Dizziness and nausea 24h after vaccine on 18Dec2020 14:30, Mild myalgias 36h after on 19Dec2020 02:30, resolved at 48h post vaccine on 19Dec2020 14:30. There was no treatment received for all the adverse events. There was no other vaccine in four weeks. The outcome of the events was Recovered.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Headache, Vaccination site erythema, Vaccination site pain
Clinical narrative: Local injection site redness swelling heat and pain/local site is very painful and still red; Local injection site redness swelling heat and pain; Local injection site redness swelling heat and pain; Local injection site redness swelling heat and pain/local site is very painful; headache; extreme fatigue; diarrhea; This is a spontaneous report from a contactable Nurse (patient). A 39-year-old female patient received the second dose of BNT162b2 (Lot number: EL1284), intramuscular in left arm on 08Jan2021 15:00 at single dose for covid-19 immunization. Medical history included Hemeplegic migraines, wolff-parkinson-white syndrome (wpw), hypertension (htn), known allergies: Penicillin (PCN) and Sulfonamide (sulfa). The patient's concomitant medication was unspecified product. The patient previously received the first dose of BNT162b2 (Lot number: EH9899), at the age of 39-year-old, intramuscular in left arm on 18Dec2020 15:00 at single dose for covid-19 immunization. The patient experienced local injection site redness swelling heat and pain. Also noted was headache, extreme fatigue and diarrhea. But local site is very painful and still red day 3. The events were occurred at 12:00 on 09Jan2021. The patient did not receive the treatment for the events. The patient was not pregnant. The outcome of the events was recovering.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site warmth
Clinical narrative: Local injection site redness swelling heat and pain/local site is very painful and still red; Local injection site redness swelling heat and pain; Local injection site redness swelling heat and pain; Local injection site redness swelling heat and pain/local site is very painful; headache; extreme fatigue; diarrhea; This is a spontaneous report from a contactable Nurse (patient). A 39-year-old female patient received the second dose of BNT162b2 (Lot number: EL1284), intramuscular in left arm on 08Jan2021 15:00 at single dose for covid-19 immunization. Medical history included Hemeplegic migraines, wolff-parkinson-white syndrome (wpw), hypertension (htn), known allergies: Penicillin (PCN) and Sulfonamide (sulfa). The patient's concomitant medication was unspecified product. The patient previously received the first dose of BNT162b2 (Lot number: EH9899), at the age of 39-year-old, intramuscular in left arm on 18Dec2020 15:00 at single dose for covid-19 immunization. The patient experienced local injection site redness swelling heat and pain. Also noted was headache, extreme fatigue and diarrhea. But local site is very painful and still red day 3. The events were occurred at 12:00 on 09Jan2021. The patient did not receive the treatment for the events. The patient was not pregnant. The outcome of the events was recovering.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: 1cm lymphadenopathy in the right groin and left supraclavicular area; This is a spontaneous report from a contactable physician (patient) reported for herself that a 32-year-old female patient (non-pregnant) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: ELIZ84) via Intramuscular at left arm, on 06Jan2021 at single dose for COVID-19 immunisation. Medical history was none. Patient has no known allergies. Concomitant medications included oral contraceptive (OCP) and cetirizine hydrochloride (ZYRTEC). Patient previously received first dose of BNT162B2 (Pfizer, Lot number: EH9S99) via intramuscular at left arm on 16Dec2020 for COVID-19 immunisation at the age of 32 years old. Patient received her Pfizer vaccines at hospital on 16Dec2020 and 06Jan2021. After her second vaccination, she had noticeable 1cm lymphadenopathy in the right groin and left supraclavicular area on 07Jan2021. No treatment received for events. Patient did not receive other vaccine in four weeks. Patient did not test COVID post vaccination. Outcome of the event was recovering.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Cough, Fatigue, Headache, Inappropriate schedule of product administration
Clinical narrative: Fever; Headache; Achy Bones; Tiredness; Cough; Start Date/Time: 22Dec2020 04:00 AM; Dose Number:1/Start Date/Time: 08Jan2021 08:45 AM;Dose Number:2; This is a spontaneous report from a contactable other HCP reporting for herself.  A 52-years-old female patient received the second dose of  bnt162b2 (BNT162B2) vaccine , on 08Jan2021 08:45 in the left arm at single dose  for Covid 19 immunization.  Medical history included drug hypersensitivity   Concomitant medication included lisdexamfetamine mesilate (VYVANSE), vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]), ergocalciferol (VIT D).  The patient received the first dose of BNT 162B2 vaccine on 22Dec2020. On 08Jan2021, the patient received the second dose of BNT162B2 vaccine earlier than expected. On 09Jan2021 the patient experienced fever, headache, achy bones, tiredness, and cough The reported events were considered non serious and their outcome was recovering  No follow-up attempts are possible: information about lot/batch number cannot be obtained. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; Headache; Achy Bones; Tiredness; Cough; Start Date/Time: 22Dec2020 04:00 AM; Dose Number:1/Start Date/Time: 08Jan2021 08:45 AM;Dose Number:2; This is a spontaneous report from a contactable other HCP reporting for herself.  A 52-years-old female patient received the second dose of  bnt162b2 (BNT162B2) vaccine , on 08Jan2021 08:45 in the left arm at single dose  for Covid 19 immunization.  Medical history included drug hypersensitivity   Concomitant medication included lisdexamfetamine mesilate (VYVANSE), vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]), ergocalciferol (VIT D).  The patient received the first dose of BNT 162B2 vaccine on 22Dec2020. On 08Jan2021, the patient received the second dose of BNT162B2 vaccine earlier than expected. On 09Jan2021 the patient experienced fever, headache, achy bones, tiredness, and cough The reported events were considered non serious and their outcome was recovering  No follow-up attempts are possible: information about lot/batch number cannot be obtained. No further information is expected.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore Army near injection site; This is a spontaneous report from a contactable consumer (patient). A 59-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number: EL1284) via an unspecified route of administration on arm left on 09Jan2021 07:30 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient did not receive other vaccine in four weeks. The patient previously took acetylsalicylic acid (aspirin) and experienced allergy. The patient was not diagnosed COVID prior vaccination. The patient was not COVID tested post vaccination. The patient experienced sore army near injection site on 10Jan2021 with outcome of recovering. No treatment received for the event.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: some arm pain but lasted several hours and mild; This is a spontaneous report from a contactable Physician (patient). A 27-year-old female patient received first dose of bnt162b2 (PFIZER- BIONTECH COVID-19 VACCINE, lot number: EJ1685) at left arm, via an unspecified route of administration on 19Dec2020 12:00 at single dose for covid-19 immunisation. The patient did not have other vaccine in four weeks. The patient did not have COVID prior vaccination. The patient had no known allergies, no other medical history. Concomitant medication included sertraline, ascorbic acid (VIT C), ergocalciferol (VIT D), zinc, cetirizine hydrochloride (ZYRTEC) and vitamin. After her first dose, the patient just had some arm pain but lasted several hours and mild on an unspecified date. The patient did not test COVID post vaccination. The outcome of event was recovered.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Diarrhoea, Fatigue, Pain
Clinical narrative: diarrhea; weakness; fatigue; low grade fever/my fever reached 102; body aches; This is a spontaneous report from a contactable Nurse(patient). A 39-year-old female patient received first dose BNT162B2 (lot number EJ1685) , via an unspecified route of administration at Arm Left on 20Dec2020 12:15 at the 39 years old at single dose for COVID-19 immunization.  The medical history included septic shock, from 2014 multi organ failure. There were no known allergies. The concomitant medications were topiramate(TROKENDI), lisdexamfetamine mesylate(VYVANSE), bupropion, sertraline, paracetamol(TYLENOL). On 22Dec2020 12:00 the patient started to have a low grade fever and body aches. On 23Dec2020 12:00 her fever reached 102 Fahrenheit, she had body aches, diarrhea, weakness and fatigue. This continued until 27Dec2020. The patient took Tylenol and Advil for fever. Tylenol and Advil helped some with fever but not always. There was no treatment received for body aches, diarrhea and weakness and fatigue. The events low grade fever, fever reached 102, body aches, diarrhea, weakness and fatigue resulted in Emergency Room Visit. There was no other vaccine in four weeks. The patient had not COVID prior vaccination. The patient had not COVID tested post vaccination. The outcome of the events was recovered on 27Dec2020.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: diarrhea; weakness; fatigue; low grade fever/my fever reached 102; body aches; This is a spontaneous report from a contactable Nurse(patient). A 39-year-old female patient received first dose BNT162B2 (lot number EJ1685) , via an unspecified route of administration at Arm Left on 20Dec2020 12:15 at the 39 years old at single dose for COVID-19 immunization.  The medical history included septic shock, from 2014 multi organ failure. There were no known allergies. The concomitant medications were topiramate(TROKENDI), lisdexamfetamine mesylate(VYVANSE), bupropion, sertraline, paracetamol(TYLENOL). On 22Dec2020 12:00 the patient started to have a low grade fever and body aches. On 23Dec2020 12:00 her fever reached 102 Fahrenheit, she had body aches, diarrhea, weakness and fatigue. This continued until 27Dec2020. The patient took Tylenol and Advil for fever. Tylenol and Advil helped some with fever but not always. There was no treatment received for body aches, diarrhea and weakness and fatigue. The events low grade fever, fever reached 102, body aches, diarrhea, weakness and fatigue resulted in Emergency Room Visit. There was no other vaccine in four weeks. The patient had not COVID prior vaccination. The patient had not COVID tested post vaccination. The outcome of the events was recovered on 27Dec2020.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: tenderness at injection site; This is a spontaneous report from a contactable other hcp (patient). The 57-years-old female patient (not pregnant) received first dose of bnt162b2 (BNT162B2, lot number: EK4176), on left arm unknown on 09Jan2021 13:30 at SINGLE DOSE for covid-19 immunisation.  Medical history was none. The patient did nor receive other vaccine in four weeks. The patient did not experience COVID prior the vaccination. The patient did not test covid post vaccination. No known allergies. Concomitant medication included alprazolam (XANAX), cetirizine hydrochloride (ZYRTEC DAIICHI), omeprazole (PRILOSEC), zolpidem tartrate (AMBIEN). The patient experienced tenderness at injection site on 10Jan2021 05:00, described as Woke up the next morning with tenderness at injection site. No swelling or redness. No treatment received for the event. The outcome of the event was recovering.  No follow-up attempts possible. No further information expected.